Emeis Stock Retreats 0.91% at Close Despite Weekly Rebound
At the close on Wednesday, January 28, 2026, Emeis stood at 14.20 euros, down 0.91% from the previous day. This slight temporary decline occurred in a context of contained volatility and after a positive weekly sequence for the specialist in care services.
Technical Consolidation Following Short-Term Gains
The decline of Emeis is part of a technical consolidation movement after a notable short-term progression. Over a week, the stock still shows an advance of 4.18%, indicating a resurgence of investor interest during this period. The one-month volatility is set at 12.19, reflecting a moderate amplitude of fluctuations.
On a quarterly scale, however, the stock loses 2.87%, illustrating a phase of hesitation after the strong recovery observed over the past year. Over twelve months, the performance remains spectacular with a jump of 132%, demonstrating a major turnaround in market sentiment towards the group.
Fragile Bullish Dynamics in the Short-Term
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
From a graphical perspective, the price is slightly above its 20-session moving average, set at 14.09 euros, which translates to a fragile bullish dynamic in the very short term. This proximity suggests a precarious balance between buyers and sellers.
The 14-period relative strength index stands at 52, placing the stock in a neutral zone, with no overbought or oversold signals. This technical configuration indicates that the market has not yet decided on a clear direction in the short term, leaving the stock in a narrow corridor of evolution around its current levels.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.